ArticleACS chemical biology2026

Discovery and Characterization of Inhibitors of Ubiquitin-Like Modifier Activating Enzyme 5 (UBA5): Targeting the UFMylation Pathway in Cancer and Neurodegenerative Diseases.

Vigyasa Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.